Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. (2022)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41590-021-01089-8
PubMed Identifier: 34937928
Publication URI: http://europepmc.org/abstract/MED/34937928
Type: Journal Article/Review
Volume: 23
Parent Publication: Nature immunology
Issue: 1
ISSN: 1529-2908